Opinion/decision on a Paediatric investigation plan (PIP): Filspari, sparsentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Uro-nephrology, PIP number: EMA/PE/0000226166

Submitted by Anonymous (not verified) on 14 July 2026 - 14:25

Opinion/decision on a Paediatric investigation plan (PIP): Filspari, sparsentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Uro-nephrology, PIP number: EMA/PE/0000226166

Opinion/decision on a Paediatric investigation plan (PIP): Alofisel, darvadstrocel, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000244768

Submitted by Anonymous (not verified) on 14 July 2026 - 14:24

Opinion/decision on a Paediatric investigation plan (PIP): Alofisel, darvadstrocel, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000244768

Human medicines European public assessment report (EPAR): Ekterly, sebetralstat, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 14 July 2026 - 14:22

Human medicines European public assessment report (EPAR): Ekterly, sebetralstat, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More